Synaptogenix Balance Sheet Health

Financial Health criteria checks 6/6

Synaptogenix has a total shareholder equity of $13.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $22.8M and $9.7M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$22.07m
EquityUS$13.12m
Total liabilitiesUS$9.71m
Total assetsUS$22.83m

Recent financial health updates

Recent updates

We Think Synaptogenix (NASDAQ:SNPX) Can Afford To Drive Business Growth

Sep 20
We Think Synaptogenix (NASDAQ:SNPX) Can Afford To Drive Business Growth

Companies Like Synaptogenix (NASDAQ:SNPX) Are In A Position To Invest In Growth

May 10
Companies Like Synaptogenix (NASDAQ:SNPX) Are In A Position To Invest In Growth

Synaptogenix: High-Risk High-Reward For Potential Alzheimer's Disease Treatment

Nov 17

Synaptogenix (NASDAQ:SNPX) Is In A Good Position To Deliver On Growth Plans

Oct 05
Synaptogenix (NASDAQ:SNPX) Is In A Good Position To Deliver On Growth Plans

Synaptogenix: The Next Big Thing In Alzheimer's

Jun 16

Synaptogenix provides update on phase 2b Alzheimer's disease trial

Jun 09

We're Keeping An Eye On Synaptogenix's (NASDAQ:SNPX) Cash Burn Rate

Jun 09
We're Keeping An Eye On Synaptogenix's (NASDAQ:SNPX) Cash Burn Rate

Financial Position Analysis

Short Term Liabilities: SNPX's short term assets ($22.3M) exceed its short term liabilities ($340.9K).

Long Term Liabilities: SNPX's short term assets ($22.3M) exceed its long term liabilities ($9.4M).


Debt to Equity History and Analysis

Debt Level: SNPX is debt free.

Reducing Debt: SNPX has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SNPX has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: SNPX has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 13.4% each year


Discover healthy companies